Loomis, Sayles & Company’s HealthEquity HQY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $77.9M | Sell |
931,906
-21,166
| -2% | -$1.74M | 0.1% | 69 |
|
|
2025
Q4 | $87.3M | Sell |
953,072
-32,033
| -3% | -$3.07M | 0.11% | 67 |
|
|
2025
Q3 | $93.4M | Sell |
985,105
-46,223
| -4% | -$4.35M | 0.11% | 63 |
|
|
2025
Q2 | $108M | Sell |
1,031,328
-81,619
| -7% | -$7.74M | 0.14% | 64 |
|
|
2025
Q1 | $98.4M | Buy |
1,112,947
+5,421
| +0.5% | +$556K | 0.14% | 66 |
|
|
2024
Q4 | $106M | Sell |
1,107,526
-19,119
| -2% | -$1.78M | 0.13% | 64 |
|
|
2024
Q3 | $92.2M | Buy |
1,126,645
+24,665
| +2% | +$1.9M | 0.12% | 72 |
|
|
2024
Q2 | $95M | Buy |
1,101,980
+171,114
| +18% | +$13.8M | 0.13% | 68 |
|
|
2024
Q1 | $76M | Buy |
930,866
+50,212
| +6% | +$3.92M | 0.11% | 81 |
|
|
2023
Q4 | $58.4M | Buy |
880,654
+480,971
| +120% | +$33.3M | 0.09% | 105 |
|
|
2023
Q3 | $29.2M | Buy |
399,683
+146,372
| +58% | +$9.89M | 0.05% | 191 |
|
|
2023
Q2 | $16M | Buy |
+253,311
| New | +$14.7M | 0.03% | 277 |
|
|
2022
Q1 | – | Sell |
-561,146
| Closed | -$24.8M | – | 1024 |
|
|
2021
Q4 | $24.8M | Sell |
561,146
-315,429
| -36% | -$18.4M | 0.03% | 278 |
|
|
2021
Q3 | $56.8M | Sell |
876,575
-13,613
| -2% | -$945K | 0.07% | 128 |
|
|
2021
Q2 | $71.6M | Buy |
890,188
+116,088
| +15% | +$8.84M | 0.09% | 99 |
|
|
2021
Q1 | $52.6M | Buy |
774,100
+234,814
| +44% | +$18.4M | 0.07% | 127 |
|
|
2020
Q4 | $37.6M | Buy |
539,286
+80,638
| +18% | +$5.02M | 0.05% | 172 |
|
|
2020
Q3 | $23.6M | Buy |
458,648
+8,710
| +2% | +$478K | 0.03% | 206 |
|
|
2020
Q2 | $26.4M | Buy |
449,938
+142,022
| +46% | +$7.85M | 0.04% | 179 |
|
|
2020
Q1 | $15.6M | Buy |
+307,916
| New | +$20.4M | 0.03% | 214 |
|
|
2018
Q4 | – | Sell |
-556,385
| Closed | -$52.5M | – | 878 |
|
|
2018
Q3 | $52.5M | Sell |
556,385
-52,620
| -9% | -$4.53M | 0.1% | 81 |
|
|
2018
Q2 | $45.7M | Sell |
609,005
-185,928
| -23% | -$13.4M | 0.09% | 92 |
|
|
2018
Q1 | $48.1M | Sell |
794,933
-24,660
| -3% | -$1.34M | 0.1% | 92 |
|
|
2017
Q4 | $38.2M | Buy |
819,593
+10,738
| +1% | +$532K | 0.08% | 130 |
|
|
2017
Q3 | $40.9M | Sell |
808,855
-23,642
| -3% | -$1.1M | 0.09% | 124 |
|
|
2017
Q2 | $41.5M | Sell |
832,497
-349
| -0% | -$16.3K | 0.1% | 107 |
|
|
2017
Q1 | $35.4M | Buy |
832,846
+36,095
| +5% | +$1.6M | 0.09% | 139 |
|
|
2016
Q4 | $32.3M | Buy |
796,751
+228,859
| +40% | +$8.85M | 0.08% | 163 |
|
|
2016
Q3 | $21.5M | Buy |
567,892
+99,337
| +21% | +$3.15M | 0.05% | 240 |
|
|
2016
Q2 | $14.2M | Buy |
+468,555
| New | +$12.3M | 0.04% | 364 |
|
|
2016
Q1 | – | Sell |
-674,778
| Closed | -$16.9M | – | 1096 |
|
|
2015
Q4 | $16.9M | Buy |
+674,778
| New | +$20.7M | 0.05% | 330 |
|
Other funds holding HQY
WA
VPM
VCM
Loomis, Sayles & Company's HQY Position: Q1 2026 in Review
Loomis, Sayles & Company reduced its HealthEquity (HQY) stake by 2.2% in Q1 2026, selling an estimated $1.74M and leaving 931,906 shares worth $77.9M. The position accounts for 0.1% of the portfolio, ranked #69.
Loomis, Sayles & Company first reported a position in HQY in Q4 2015 and has held it in 31 quarters since. The position peaked at $108M in Q2 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.
- Loomis, Sayles & Company held 931,906 shares of HealthEquity worth $77.9M as of Q1 2026.
- Loomis, Sayles & Company sold 21,166 HealthEquity shares in Q1 2026, an estimated $1.74M.
- HealthEquity made up 0.1% of Loomis, Sayles & Company's portfolio in Q1 2026, its #69 holding.
- Loomis, Sayles & Company first reported a position in HealthEquity in Q4 2015 and has held it in 31 quarters since.
- Loomis, Sayles & Company's HealthEquity position peaked at $108M in Q2 2025.
- 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.
Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.